Research ExplorerScientific StaffPhilippe Schafhausen Publications

Dr.med. ID: 32737

Philippe Schafhausen

graph of relations
Affiliations
1 - 50 out of 80Page size: 50

Publications

  1. 2024

  2. Kopf-Hals-Tumoren

    Schafhausen, P., 14.10.2024, Colloquium Onkologie 31: Update Hämatologie / Onkologie. Ehninger, G., F. O. & Petrasch, S. (eds.). 1. ed. München: Lukon Verlagsgesellschaft mbH München, Vol. 31. p. 177-200 23 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education › peer-review

  3. International consensus statement on allergy and rhinology: Sinonasal tumors

    Kuan, E. C., Wang, E. W., Adappa, N. D., Beswick, D. M., London, N. R., Su, S. Y., Wang, M. B., Abuzeid, W. M., Alexiev, B., Alt, J. A., Antognoni, P., Alonso-Basanta, M., Batra, P. S., Bhayani, M., Bell, D., Bernal-Sprekelsen, M., Betz, C. S., Blay, J-Y., Bleier, B. S., Bonilla-Velez, J., Callejas, C., Carrau, R. L., Casiano, R. R., Castelnuovo, P., Chandra, R. K., Chatzinakis, V., Chen, S. B., Chiu, A. G., Choby, G., Chowdhury, N. I., Citardi, M. J., Cohen, M. A., Dagan, R., Dalfino, G., Dallan, I., Dassi, C. S., de Almeida, J., Tos, A. P. D., DelGaudio, J. M., Ebert, C. S., El-Sayed, I. H., Eloy, J. A., Evans, J. J., Fang, C. H., Farrell, N. F., Ferrari, M., Fischbein, N., Folbe, A., Fokkens, W. J., Fox, M. G., Lund, V. J., Gallia, G. L., Gardner, P. A., Geltzeiler, M., Georgalas, C., Getz, A. E., Govindaraj, S., Gray, S. T., Grayson, J. W., Gross, B. A., Grube, J. G., Guo, R., Ha, P. K., Halderman, A. A., Hanna, E. Y., Harvey, R. J., Hernandez, S. C., Holtzman, A. L., Hopkins, C., Huang, Z., Huang, Z., Humphreys, I. M., Hwang, P. H., Iloreta, A. M., Ishii, M., Ivan, M. E., Jafari, A., Kennedy, D. W., Khan, M., Kimple, A. J., Kingdom, T. T., Knisely, A., Kuo, Y-J., Lal, D., Lamarre, E. D., Lan, M-Y., Le, H., Lechner, M., Lee, N. Y., Lee, J. K., Lee, V. H., Levine, C. G., Lin, J-C., Lin, D. T., Lobo, B. C., Locke, T., Luong, A. U., Magliocca, K. R., Markovic, S. N., Matnjani, G., McKean, E. L., Meço, C., Mendenhall, W. M., Michel, L., Na'ara, S., Nicolai, P., Nuss, D. W., Nyquist, G. G., Oakley, G. M., Omura, K., Orlandi, R. R., Otori, N., Papagiannopoulos, P., Patel, Z. M., Pfister, D. G., Phan, J., Psaltis, A. J., Rabinowitz, M. R., Ramanathan, M., Rimmer, R., Rosen, M. R., Sanusi, O., Sargi, Z. B., Schafhausen, P., Schlosser, R. J., Sedaghat, A. R., Senior, B. A., Shrivastava, R., Sindwani, R., Smith, T. L., Smith, K. A., Snyderman, C. H., Solares, C. A., Sreenath, S. B., Stamm, A., Stölzel, K., Sumer, B., Surda, P., Tajudeen, B. A., Thompson, L. D. R., Thorp, B. D., Tong, C. C. L., Tsang, R. K., Turner, J. H., Turri-Zanoni, M., Udager, A. M., van Zele, T., VanKoevering, K., Welch, K. C., Wise, S. K., Witterick, I. J., Won, T-B., Wong, S. N., Woodworth, B. A., Wormald, P-J., Yao, W. C., Yeh, C-F., Zhou, B. & Palmer, J. N., 02.2024, In: INT FORUM ALLERGY RH. 14, 2, p. 149-608 460 p.

    Research output: SCORING: Contribution to journal › Guideline, recommendation, statement › Research › peer-review

  4. 2023

  5. Step-in dosing of bosutinib in pts with chronic phase chronic myeloid leukemia (CML) after second-generation tyrosine kinase inhibitor (TKI) therapy: results of the Bosutinib Dose Optimization (BODO) Study

    Isfort, S., Manz, K., Teichmann, L. L., Crysandt, M., Burchert, A., Hochhaus, A., Saussele, S., Kiani, A., Göthert, J. R., Illmer, T., Schafhausen, P., Al-Ali, H. K., Stegelmann, F., Hänel, M., Pfeiffer, T., Giagounidis, A., Franke, G-N., Koschmieder, S., Fabarius, A., Ernst, T., Warnken-Uhlich, M., Wolber, U., Kohn, D., Pfirrmann, M., Wolf, D., Brümmendorf, T. H. & German CML study group, 10.2023, In: ANN HEMATOL. 102, 10, p. 2741-2752 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  6. Avapritinib versus Placebo in Indolent Systemic Mastocytosis

    Gotlib, J., Castells, M., Elberink, H. O., Siebenhaar, F., Hartmann, K., Broesby-Olsen, S., George, T. I., Panse, J., Alvarez-Twose, I., Radia, D. H., Tashi, T., Bulai Livideanu, C., Sabato, V., Heaney, M., Van Daele, P., Cerquozzi, S., Dybedal, I., Reiter, A., Pongdee, T., Barete, S., Ustun, C., Schwartz, L., Ward, B. R., Schafhausen, P., Vadas, P., Bose, P., DeAngelo, D. J., Rein, L., Vachhani, P., Triggiani, M., Bonadonna, P., Rafferty, M., Butt, N. M., Oh, S. T., Wortmann, F., Ungerstedt, J., Guilarte, M., Taparia, M., Kuykendall, A. T., Arana Yi, C., Ogbogu, P., Gaudy-Marqueste, C., Mattsson, M., Shomali, W., Giannetti, M. P., Bidollari, I., Lin, H-M., Sulllivan, E., Mar, B. & Maurer, M., 23.05.2023, In: NEJM Evidence. 2023, 2, 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  7. Identification of Adult Patients With Classical Dyskeratosis Congenita or Cryptic Telomere Biology Disorder by Telomere Length Screening Using Age-modified Criteria

    Tometten, M., Kirschner, M., Meyer, R., Begemann, M., Halfmeyer, I., Vieri, M., Kricheldorf, K., Maurer, A., Platzbecker, U., Radsak, M., Schafhausen, P., Corbacioglu, S., Höchsmann, B., Matthias Wilk, C., Hinze, C., Chromik, J., Heuser, M., Kreuter, M., Koschmieder, S., Panse, J., Isfort, S., Kurth, I., Brümmendorf, T. H. & Beier, F., 05.2023, In: HEMASPHERE. 7, 5, p. e874

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  8. Efficacy and safety of ruxolitinib in patients with newly-diagnosed polycythemia vera: futility analysis of the RuxoBEAT clinical trial of the GSG-MPN study group

    Koschmieder, S., Isfort, S., Wolf, D., Heidel, F. H., Hochhaus, A., Schafhausen, P., Griesshammer, M., Wolleschak, D., Platzbecker, U., Döhner, K., Jost, P. J., Parmentier, S., Schaich, M., von Bubnoff, N., Stegelmann, F., Maurer, A., Crysandt, M., Gezer, D., Kortmann, M., Franklin, J., Frank, J., Hellmich, M., Brümmendorf, T. H. & German Study Group for Myeloproliferative Neoplasms (GSG-MPN), 02.2023, In: ANN HEMATOL. 102, 2, p. 349-358 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  9. Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma

    Rieke, D. T., Schröder, S., Schafhausen, P., Blanc, E., Zuljan, E., von der Emde, B., Beule, D., Keller, U., Keilholz, U. & Klinghammer, K., 2023, In: FRONT ONCOL. 13, p. 1107134

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  10. 2022

  11. Evaluation of different diagnostic tools for detection of acquired von Willebrand syndrome in patients with polycythemia vera or essential thrombocythemia

    Janjetovic, S., Rolling, C. C., Budde, U., Schneppenhem, S., Schafhausen, P., Peters, M. C., Bokemeyer, C., Holstein, K. & Langer, F., 10.2022, In: THROMB RES. 218, p. 35-43 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  12. Risk factors for poor humoral response to primary and booster SARS-CoV-2 vaccination in hematologic and oncological outpatients-COVIDOUT study

    Schönlein, M., Wrage, V., Ghandili, S., Mellinghoff, S. C., Brehm, T. T., Leypoldt, L. B., Utz, N., Schrader, R. M., Alsdorf, W., Börschel, N., Bußmann, L., Schönrock, M., Perlick, D., Schön, G., Verpoort, K., Lütgehetmann, M., Schulze Zur Wiesch, J., Weisel, K. C., Bokemeyer, C., Schafhausen, P. & Sinn, M., 13.06.2022, In: CANCER CELL. 40, 6, p. 581-583 3 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  13. Impact of single-room contact precautions on acquisition and transmission of vancomycin-resistant enterococci on haematological and oncological wards, multicentre cohort-study, Germany, January-December 2016

    Biehl, L. M., Higgins, P. G., Stemler, J., Gilles, M., Peter, S., Dörfel, D., Vogel, W., Kern, W. V., Gölz, H., Bertz, H., Rohde, H., Klupp, E-M., Schafhausen, P., Salmanton-García, J., Stecher, M., Wille, J., Liss, B., Xanthopoulou, K., Zweigner, J., Seifert, H. & Vehreschild, M. J. G. T., 01.2022, In: EUROSURVEILLANCE. 27, 2, 2001876.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  14. Kopf-Hals-Tumoren

    Schafhausen, P., 2022, Colloquium Onkologie 30: Update Hämatologie / Onkologie. Petrasch, S. & Ehninger, G. (eds.). Lukon Verlagsgesellschaft mbH München, Vol. 30. p. 161-171 11 p.

    Research output: SCORING: Contribution to book/anthology › SCORING: Contribution to collected editions/anthologies › Education

  15. 2021

  16. 83/m mit Schwellung am Hals: Vorbereitung auf die Facharztprüfung: Fall 24

    Zech, H. B., Schafhausen, P. & Bußmann, L., 30.11.2021, In: ONKOLOGE.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Education

  17. AXL Inhibition Represents a Novel Therapeutic Approach in BCR-ABL Negative Myeloproliferative Neoplasms

    Beitzen-Heineke, A., Berenbrok, N., Waizenegger, J. S., Päsler, S., Gensch, V., Udonta, F., Vargas-Delgado, M. E., Engelmann, J., Hoffmann, F., Schafhausen, P., von Amsberg, G., Riecken, K., Beumer, N., Imbusch, C. D., Lorens, J. B., Fischer, T., Pantel, K., Bokemeyer, C., Ben Batalla, I. & Loges, S., 09.2021, In: HEMASPHERE. 5, 9, e630.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Genome-wide DNA methylation analysis pre- and post-lenalidomide treatment in patients with myelodysplastic syndrome with isolated deletion (5q)

    Hecht, A., Meyer, J. A., Jann, J-C., Sockel, K., Giagounidis, A., Götze, K. S., Letsch, A., Haase, D., Schlenk, R. F., Haferlach, T., Schafhausen, P., Bug, G., Lübbert, M., Thol, F., Büsche, G., Schuler, E., Nowak, V., Obländer, J., Fey, S., Müller, N., Metzgeroth, G., Hofmann, W-K., Germing, U., Nolte, F., Reinwald, M. & Nowak, D., 06.2021, In: ANN HEMATOL. 100, 6, p. 1463-1471 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. Cetuximab, docetaxel, and cisplatin versus platinum, fluorouracil, and cetuximab as first-line treatment in patients with recurrent or metastatic head and neck squamous-cell carcinoma (GORTEC 2014-01 TPExtreme): a multicentre, open-label, randomised, phase 2 trial

    Guigay, J., Aupérin, A., Fayette, J., Saada-Bouzid, E., Lafond, C., Taberna, M., Geoffrois, L., Martin, L., Capitain, O., Cupissol, D., Castanie, H., Vansteene, D., Schafhausen, P., Johnson, A., Even, C., Sire, C., Duplomb, S., Evrard, C., Delord, J-P., Laguerre, B., Zanetta, S., Chevassus-Clément, C., Fraslin, A., Louat, F., Sinigaglia, L., Keilholz, U., Bourhis, J., Mesia, R. & GORTEC, 04.2021, In: LANCET ONCOL. 22, 4, p. 463-475 13 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  20. Prevalence of definite antiphospholipid syndrome in carriers of the JAK2V617F mutation

    Janjetovic, S., Beckmann, L., Holstein, K., Rolling, C., Thiele, B., Schafhausen, P., Schön, G., Bokemeyer, C., Langer, F. & Voigtlaender, M., 02.2021, In: THROMB RES. 198, p. 55-61 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2020

  22. Phase III study of nivolumab alone or combined with ipilimumab as immunotherapy versus standard of care in resectable head and neck squamous cell carcinoma

    Zech, H. B., Moeckelmann, N., Boettcher, A., Muenscher, A., Binder, M., Vettorazzi, E., Bokemeyer, C., Schafhausen, P., Betz, C. S. & Busch, C-J., 12.2020, In: FUTURE ONCOL. 16, 36, p. 3035-3043 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

    Horne, G. A., Stobo, J., Kelly, C., Mukhopadhyay, A., Latif, A. L., Dixon-Hughes, J., McMahon, L., Cony-Makhoul, P., Byrne, J., Smith, G., Koschmieder, S., BrÜmmendorf, T. H., Schafhausen, P., Gallipoli, P., Thomson, F., Cong, W., Clark, R. E., Milojkovic, D., Helgason, G. V., Foroni, L., Nicolini, F. E., Holyoake, T. L. & Copland, M., 07.2020, In: LEUKEMIA. 34, 7, p. 1775-1786 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. Implications of SARS-CoV-2 Infection and COVID-19 Crisis on Clinical Cancer Care: Report of the University Cancer Center Hamburg: Report of the University Cancer Center Hamburg

    Weisel, K. C., Morgner-Miehlke, A., Petersen, C., Fiedler, W., Block, A., Schafhausen, P., Knobloch, J. K. & Bokemeyer, C., 07.05.2020, In: ONCOL RES TREAT. 43, 6, p. 307-313 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  25. 2019

  26. Fulminant blast crisis with de novo 11q23 rearrangement in a Philadelphia-positive CML patient undergoing treatment with dasatinib

    Janjetovic, S., Asemissen, A. M., Dicker, F., Binder, M., Dierlamm, J., Bokemeyer, C. & Schafhausen, P., 12.2019, In: TUMORI J. 105, 6, p. NP8-NP11

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  27. Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs: Highlights des ASCO-Meetings 2019

    Zech, H. B., Laban, S., Schafhausen, P., Bussmann, L., Betz, C. & Busch, C-J., 12.2019, In: HNO. 67, 12, p. 898-904 7 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  28. Impact of single-room contact precautions on hospital-acquisition and transmission of multidrug-resistant Escherichia coli: a prospective multicentre cohort study in haematological and oncological wards

    Biehl, L. M., Higgins, P., Wille, T., Peter, K., Hamprecht, A., Peter, S., Dörfel, D., Vogel, W., Häfner, H., Lemmen, S., Panse, J., Rohde, H., Klupp, E-M., Schafhausen, P., Imirzalioglu, C., Falgenhauer, L., Salmanton-García, J., Stecher, M., Vehreschild, J. J., Seifert, H. & Vehreschild, M. J. G. T., 08.2019, In: CLIN MICROBIOL INFEC. 25, 8, p. 1013-1020 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  29. Controlling intestinal colonization of high-risk haematology patients with ESBL-producing Enterobacteriaceae: a randomized, placebo-controlled, multicentre, Phase II trial (CLEAR)

    Dimitriou, V., Biehl, L. M., Hamprecht, A., Vogel, W., Dörfel, D., Peter, S., Schafhausen, P., Rohde, H., von Lilienfeld-Toal, M., Klassert, T. E., Slickers, P., Ehricht, R., Slevogt, H., Christ, H., Hellmich, M., Farowski, F., Tsakmaklis, A., Higgins, P. G., Seifert, H. & Vehreschild, M. J. G. T., 01.07.2019, In: J ANTIMICROB CHEMOTH. 74, 7, p. 2065-2074 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  30. Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV

    Michel, C., Burchert, A., Hochhaus, A., Saussele, S., Neubauer, A., Lauseker, M., Krause, S. W., Kolb, H-J., Hossfeld, D. K., Nerl, C., Baerlocher, G. M., Heim, D., Brümmendorf, T. H., Fabarius, A., Haferlach, C., Schlegelberger, B., Balleisen, L., Goebeler, M-E., Hänel, M., Ho, A., Dengler, J., Falge, C., Möhle, R., Kremers, S., Kneba, M., Stegelmann, F., Köhne, C-H., Lindemann, H-W., Waller, C. F., Spiekermann, K., Berdel, W. E., Müller, L., Edinger, M., Mayer, J., Beelen, D. W., Bentz, M., Link, H., Hertenstein, B., Fuchs, R., Wernli, M., Schlegel, F., Schlag, R., de Wit, M., Trümper, L., Hebart, H., Hahn, M., Thomalla, J., Scheid, C., Schafhausen, P., Verbeek, W., Eckart, M. J., Gassmann, W., Schenk, M., Brossart, P., Wündisch, T., Geer, T., Bildat, S., Schäfer, E., Hasford, J., Hehlmann, R. & Pfirrmann, M., 05.2019, In: HAEMATOLOGICA. 104, 5, p. 955-962 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  31. Usability of rectal swabs for microbiome sampling in a cohort study of hematological and oncological patients

    Biehl, L. M., Garzetti, D., Farowski, F., Ring, D., Koeppel, M. B., Rohde, H., Schafhausen, P., Stecher, B. & Vehreschild, M. J. G. T., 2019, In: PLOS ONE. 14, 4, p. e0215428

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  32. 2018

  33. Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase I/II study

    Gambacorti-Passerini, C., Cortes, J. E., Lipton, J. H., Kantarjian, H. M., Kim, D-W., Schafhausen, P., Crescenzo, R., Bardy-Bouxin, N., Shapiro, M., Noonan, K., Leip, E., DeAnnuntis, L., Brümmendorf, T. H. & Khoury, H. J., 08.2018, In: HAEMATOLOGICA. 103, 8, p. 1298-1307 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  34. 2017

  35. Induction chemotherapy followed by radiochemotherapy for locally advanced head and neck cancer as an individual treatment approach-Feasibility, safety and retrospective survival analysis in twenty-three patients

    Busch, C-J., Girke, J., Tribius, S., Bussmann, L., Knecht, R., Schafhausen, P., Lörincz, B. B. & Münscher, A., 12.2017, In: CLIN OTOLARYNGOL. 42, 6, p. 1392-1396

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  36. Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants

    Hehlmann, R., Lauseker, M., Saußele, S., Pfirrmann, M., Krause, S., Kolb, H. J., Neubauer, A., Hossfeld, D. K., Nerl, C., Gratwohl, A., Baerlocher, G. M., Heim, D., Brümmendorf, T. H., Fabarius, A., Haferlach, C., Schlegelberger, B., Müller, M. C., Jeromin, S., Proetel, U., Kohlbrenner, K., Voskanyan, A., Rinaldetti, S., Seifarth, W., Spieß, B., Balleisen, L., Goebeler, M. C., Hänel, M., Ho, A., Dengler, J., Falge, C., Kanz, L., Kremers, S., Burchert, A., Kneba, M., Stegelmann, F., Köhne, C. A., Lindemann, H. W., Waller, C. F., Pfreundschuh, M., Spiekermann, K., Berdel, W. E., Müller, L., Edinger, M., Mayer, J., Beelen, D. W., Bentz, M., Link, H., Hertenstein, B., Fuchs, R., Wernli, M., Schlegel, F., Schlag, R., de Wit, M., Trümper, L., Hebart, H., Hahn, M., Thomalla, J., Scheid, C., Schafhausen, P., Verbeek, W., Eckart, M. J., Gassmann, W., Pezzutto, A., Schenk, M., Brossart, P., Geer, T., Bildat, S., Schäfer, E., Hochhaus, A. & Hasford, J., 11.2017, In: LEUKEMIA. 31, 11, p. 2398-2406 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  37. Peripheral blood cytogenetics allows treatment monitoring and early identification of treatment failure to lenalidomide in MDS patients: results of the LE-MON-5 trial

    Braulke, F., Schulz, X., Germing, U., Schuler, E., Platzbecker, U., Nolte, F., Hofmann, W-K., Giagounidis, A., Götze, K., Lübbert, M., Schlenk, R. F., Schanz, J., Bacher, U., Ganser, A., Büsche, G., Letsch, A., Schafhausen, P., Bug, G., Brümmendorf, T. H., Haas, R., Trümper, L., Shirneshan, K. & Haase, D., 06.2017, In: ANN HEMATOL. 96, 6, p. 887-894 8 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  38. Axl Blockade by BGB324 Inhibits BCR-ABL Tyrosine Kinase Inhibitor-Sensitive and -Resistant Chronic Myeloid Leukemia

    Ben Batalla, I., Erdmann, R., Jørgensen, H., Mitchell, R., Ernst, T., von Amsberg, G., Schafhausen, P., Velthaus, J. L., Rankin, S., Clark, R. E., Koschmieder, S., Schultze, A., Mitra, S., Vandenberghe, P., Brümmendorf, T. H., Carmeliet, P., Hochhaus, A., Pantel, K., Bokemeyer, C., Helgason, G. V., Holyoake, T. L. & Loges, S., 01.05.2017, In: CLIN CANCER RES. 23, 9, p. 2289-2300

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  39. Pomalidomide in myeloproliferative neoplasm-associated myelofibrosis

    Schlenk, R. F., Stegelmann, F., Reiter, A., Jost, E., Gattermann, N., Hebart, H., Waller, C., Hochhaus, A., Platzbecker, U., Schafhausen, P., Blau, I. W., Verbeek, W., Heidel, F. H., Werner, M., Kreipe, H., Teleanu, V., Benner, A., Döhner, H., Grießhammer, M. & Döhner, K., 04.2017, In: LEUKEMIA. 31, 4, p. 889-895

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  40. Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia:the SEPIA Study

    Koehler, P., Hamprecht, A., Bader, O., Bekeredjian-Ding, I., Buchheidt, D., Doelken, G., Elias, J., Haase, G., Hahn-Ast, C., Karthaus, M., Kekulé, A., Keller, P., Kiehl, M., Krause, S. W., Krämer, C., Neumann, S., Rohde, H., La Rosée, P., Ruhnke, M., Schafhausen, P., Schalk, E., Schulz, K., Schwartz, S., Silling, G., Staib, P., Ullmann, A., Vergoulidou, M., Weber, T., Cornely, O. A. & Vehreschild, M. J. G. T., 02.2017, In: INT J ANTIMICROB AG. 49, 2, p. 218-223

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  41. 2016

  42. Long-term bosutinib for chronic phase chronic myeloid leukemia after failure of imatinib plus dasatinib and/or nilotinib

    Cortes, J. E., Khoury, H. J., Kantarjian, H. M., Lipton, J. H., Kim, D-W., Schafhausen, P., Matczak, E., Leip, E., Noonan, K., Brümmendorf, T. H. & Gambacorti-Passerini, C., 12.2016, In: AM J HEMATOL. 91, 12, p. 1206-1214 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  43. Prevalence, clonal dynamics and clinical impact of TP53 mutations in patients with myelodysplastic syndrome with isolated deletion (5q) treated with lenalidomide: results from a prospective multicenter study of the german MDS study group (GMDS)

    Mossner, M., Jann, J-C., Nowak, D., Platzbecker, U., Giagounidis, A., Götze, K., Letsch, A., Haase, D., Shirneshan, K., Braulke, F., Schlenk, R. F., Haferlach, T., Schafhausen, P., Bug, G., Lübbert, M., Ganser, A., Büsche, G., Schuler, E., Nowak, V., Pressler, J., Obländer, J., Fey, S., Müller, N., Lauinger-Lörsch, E., Metzgeroth, G., Weiß, C., Hofmann, W-K., Germing, U. & Nolte, F., 09.2016, In: LEUKEMIA. 30, 9, p. 1956-9 4 p.

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  44. Safety and efficacy of ruxolitinib in an open-label, multicenter, single-arm phase 3b expanded-access study in patients with myelofibrosis: a snapshot of 1144 patients in the JUMP trial

    Al-Ali, H. K., Griesshammer, M., le Coutre, P., Waller, C. F., Liberati, A. M., Schafhausen, P., Tavares, R., Giraldo, P., Foltz, L., Raanani, P., Gupta, V., Tannir, B., Ronco, J. P., Ghosh, J., Martino, B. & Vannucchi, A. M., 09.2016, In: HAEMATOLOGICA. 101, 9, p. 1065-73 9 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  45. Results of a multicenter prospective phase II trial investigating the safety and efficacy of lenalidomide in patients with myelodysplastic syndromes with isolated del(5q) (LE-MON 5)

    Schuler, E., Giagounidis, A., Haase, D., Shirneshan, K., Büsche, G., Platzbecker, U., Nolte, F., Götze, K., Schlenk, R. F., Ganser, A., Letsch, A., Braulke, F., Lübbert, M., Bug, G., Schafhausen, P., Bacher, U., Gattermann, N., Wulfert, M., Haas, R. & Germing, U., 07.2016, In: LEUKEMIA. 30, 7, p. 1580-2

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  46. Outcome and fewer indications for adjuvant therapy for patients with oral squamous cell carcinomas under standardized tumor board conditions

    Gröbe, A., Rybak, L., Schön, G., Smeets, R., Tribius, S., Schafhausen, P., Clauditz, T. S., Hanken, H. & Heiland, M., 02.2016, In: J CANCER RES CLIN. 142, 2, p. 505-20

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  47. Factors influencing long-term efficacy and tolerability of bosutinib in chronic phase chronic myeloid leukaemia resistant or intolerant to imatinib

    Brümmendorf, T. H., Cortes, J. E., Khoury, H. J., Kantarjian, H. M., Kim, D-W., Schafhausen, P., Conlan, M. G., Shapiro, M., Turnbull, K., Leip, E., Gambacorti-Passerini, C. & Lipton, J. H., 01.2016, In: BRIT J HAEMATOL. 172, 1, p. 97-110 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  48. Management of sinonasal undifferentiated carcinoma with intracerebral invasion: Clinical experience at a single institution and review of the literature

    Zielinski, V., Laban, S., Tribius, S., Schafhausen, P., Veldhoen, S., Knecht, R., Clauditz, T. & Muenscher, A., 01.2016, In: ENT-EAR NOSE THROAT. 95, 1, p. 23-8 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  49. 2015

  50. Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1):an open-label, randomised phase 3 trial

    Machiels, J-P. H., Haddad, R. I., Fayette, J., Licitra, L. F., Tahara, M., Vermorken, J. B., Clement, P. M., Gauler, T., Cupissol, D., Grau, J. J., Guigay, J., Caponigro, F., de Castro, G., de Souza Viana, L., Keilholz, U., Del Campo, J. M., Cong, X. J., Ehrnrooth, E., Cohen, E. E. W. & LUX-H&N 1 investigators, 05.2015, In: LANCET ONCOL. 16, 5, p. 583-94 12 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  51. A phase I study of Danusertib (PHA-739358) in adult patients with accelerated or blastic phase chronic myeloid leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia resistant or intolerant to imatinib and/or other second generation c-ABL therapy

    Borthakur, G., Dombret, H., Schafhausen, P., Brummendorf, T. H., Boissel, N., Jabbour, E., Mariani, M., Capolongo, L., Carpinelli, P., Davite, C., Kantarjian, H. & Cortes, J. E., 17.04.2015, In: HAEMATOLOGICA.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  52. The current role of systemic chemotherapy in the primary treatment of head and neck cancer

    Busch, C-J., Tribius, S., Schafhausen, P. & Knecht, R., 01.03.2015, In: CANCER TREAT REV. 41, 3, p. 217-21 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  53. Clonal Evolution and Blast Crisis Correlate with Enhanced Proteolytic Activity of Separase in BCR-ABL b3a2 Fusion Type CML under Imatinib Therapy

    Haaß, W., Kleiner, H., Weiß, C., Haferlach, C., Schlegelberger, B., Müller, M. C., Hehlmann, R., Hofmann, W-K., Fabarius, A., Seifarth, W. & Schweizerische Arbeitsgemeinschaft für Klinische Krebsforschung / German CML Study Group., 2015, In: PLOS ONE. 10, 6, p. e0129648

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  54. 2014

  55. A multicentre cohort study on colonization and infection with ESBL-producing Enterobacteriaceae in high-risk patients with haematological malignancies

    Vehreschild, M. J. G. T., Hamprecht, A., Peterson, L., Schubert, S., Häntschel, M., Peter, S., Schafhausen, P., Rohde, H., Lilienfeld-Toal, M. V., Bekeredjian-Ding, I., Libam, J., Hellmich, M., Vehreschild, J. J., Cornely, O. A. & Seifert, H., 01.12.2014, In: J ANTIMICROB CHEMOTH. 69, 12, p. 3387-92 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  56. Therapie der rezidivierten und fernmetastasierten Plattenepithelkarzinome des Kopf-Hals-Bereichs: Highlights des ASCO-Meetings 2014

    Zeller, N., Busch, C-J., Schafhausen, P., Knecht, R. & Möckelmann, N., 01.11.2014, In: HNO. 62, 11, p. 787-92 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  57. Induktionschemotherapie bei lokal fortgeschrittenen Kopf-Hals-Karzinomen – pro

    Knecht, R., Busch, C-J. & Schafhausen, P., 01.10.2014, In: DEUT MED WOCHENSCHR. 139, 41, p. 2080

    Research output: SCORING: Contribution to journal › Other (editorial matter etc.) › Research

  58. Sequential neoadjuvant chemoradiotherapy (CRT) followed by curative surgery vs. primary surgery alone for resectable, non-metastasized pancreatic adenocarcinoma: NEOPA- a randomized multicenter phase III study (NCT01900327, DRKS00003893)

    Tachezy, M., Gebauer, F., Petersen, C., Arnold, D., Trepel, M., Wegscheider, K., Schafhausen, P., Bockhorn, M., Izbicki, J. R. & Yekebas, E., 07.06.2014, In: BMC CANCER. 14, 1, p. 411

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  59. Mast cell sarcoma mimicking metastatic colon carcinoma

    Schwaab, J., Horny, H. P., Jonescheit, J., Metzgeroth, G., Schafhausen, P., Gaiser, T., Marx, A., Kienle, P., Hofmann, W. K. & Reiter, A., 01.06.2014, In: ANN HEMATOL. 93, 6, p. 1067-9 3 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  60. Cisplatin, 5-fluorouracil, and cetuximab (PFE) with or without cilengitide in recurrent/metastatic squamous cell carcinoma of the head and neck: results of the randomized phase I/II ADVANTAGE trial (phase II part)

    Vermorken, J. B., Peyrade, F., Krauss, J., Mesía, R., Remenar, E., Gauler, T. C., Keilholz, U., Delord, J. P., Schafhausen, P., Erfán, J., Brümmendorf, T. H., Iglesias, L., Bethe, U., Hicking, C. & Clement, P. M., 01.03.2014, In: ANN ONCOL. 25, 3, p. 682-8 7 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  61. Bosutinib: a novel second-generation tyrosine kinase inhibitor

    Isfort, S., Amsberg, G., Schafhausen, P., Koschmieder, S. & Brümmendorf, T. H., 01.01.2014, In: Recent Results Cancer Res. 201, p. 81-97 17 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Previous 1 2 Next